Nafamostat mesylate (CAS: 82956-11-4) is a medication that is used to treat various medical conditions, including pancreatitis, disseminated intravascular coagulation (DIC), and COVID-19. This product works by inhibiting certain enzymes in the body that play a role in blood clotting and inflammation.
Chemical name: 6-amidino-2-naphthyl 4-guanidinobenzoate methanesulfonate
Molecular formula: C19H17N5O2 · CH3SO3H
Formula weight: 495.59 g/mol
CAS No: 82956-11-4
Top ten keywords from Google and Synonyms:
Synonyms: Fusan, Nafamostat mesilate, Mesylate de nafamostat
Health benefits of Nafamostat mesylate:
The primary health benefit of Nafamostat mesylate is its ability to inhibit enzymes that play a role in blood clotting and inflammation. This medication has been shown to be effective in treating pancreatitis, DIC, and COVID-19, among other conditions.
Potential effects of Nafamostat mesylate:
Nafamostat mesylate works by inhibiting enzymes called serine proteases, including thrombin and factor Xa. By doing so, it can help prevent blood clots and reduce inflammation in the body. Additionally, this medication may have antiviral properties that make it effective against viruses such as COVID-19.
Product mechanism:
Nafamostat mesylate works by inhibiting serine proteases, which are enzymes that play a key role in blood clotting and inflammation. Specifically, this medication inhibits thrombin and factor Xa, two important enzymes involved in blood clotting.
Safety:
Nafamostat mesylate is generally considered safe when taken as directed by a healthcare provider. However, like any medication, it does carry some risks and potential side effects. Before taking this medication, patients should discuss their medical history and any current medications with their healthcare provider to ensure that it is safe for them to take.
Side effects of Nafamostat mesylate:
Common side effects of Nafamostat mesylate include nausea, vomiting, and diarrhea. More serious side effects are rare, but may include allergic reactions, liver damage, and bleeding disorders. Patients who experience any of these symptoms while taking this medication should contact their healthcare provider immediately.
Dosing information:
The recommended dose of Nafamostat mesylate varies depending on the patient's medical history and condition. It is important for patients to follow their healthcare provider's instructions regarding dosing and administration of this medication.
Conclusion:
Nafamostat mesylate is a medication that is used to treat various medical conditions, including pancreatitis, DIC, and COVID-19. By inhibiting enzymes that play a role in blood clotting and inflammation, this medication can help prevent blood clots and reduce inflammation in the body. While generally considered safe, this medication does carry some risks and potential side effects, so patients should discuss their medical history and any current medications with their healthcare provider before taking it. Overall, Nafamostat mesylate is an effective medication with many potential health benefits
